London Calling 2024 - Speakers
Speakers
Check out the line up of speaking at London Calling 2024.
A
)
Dr. Ahmad Abou TayounAl Jalila Children’s Specialty Hospital & Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, UAE
Antoni P.A. HendrickxNational Institute for Public Health and the Environment, Netherlands
)
Andre HolzerHolzer Scientific Consultancy, Germany
)
Anoushka JoglekarNew York Genome Center, USA
)
Adrien LegerDirector, Modified Base Research, Oxford Nanopore Technologies
)
Alex ShawImperial College London, UK
)
Alex TrotterDevelopment Scientist – Translational Development, Oxford Nanopore Technologies
)
Alexander WittenbergKeyGene, Netherlands
)
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
)
Bryant CatanoSenior Product Support Scientist, Oxford Nanopore Technologies
)
Prof. Benjamin KippMayo Clinic, USA
)
Bosheng LiInstitute of Advanced Agricultural Sciences, Peking University, China
)
Ben PriceNatural History Museum, UK
C
)
Claire AndersonUniversity College London, UK
)
Chris AlderBioinformatician, Oxford Nanopore Technologies
)
Clive BrownChief Technology, Innovation, and Product Officer, Oxford Nanopore Technologies
)
Chao Chun LiuSimon Fraser University, Canada
Dr. Chuck CooperbioMérieux, France
)
Dr. Charles K. CooperbioMérieux, France
)
Dr. Clemens JakobiLonza, Switzerland
)
Dr. Carolyn TregidgoVP, Late Stage and Applied Product Development, Oxford Nanopore Technologies
D
)
Daniel BrantonHarvard University, USA
)
David W. DeamerUniversity of California, Santa Cruz, USA
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
)
Dr. Danny E. MillerUniversity of Washington, USA
)
Devin OglesbeeMayo Clinic, USA
E
)
Prof. Emma BapleUniversity of Exeter and South West NHS Genomics Laboratory Hub, UK
)
Ethan Hill‘Iolani School, USA
)
Emma WhiteVP, Marketing Operations, Oxford Nanopore Technologies
)
Eddy de BoerUniversity Medical Center Groningen, Netherlands
)
H
)
Dr. Helen Bulbeckbrainstrust, UK
)
Hagan BayleyUniversity of Oxford, UK
)
Dr. Helen GunterBASE mRNA Facility, The University of Queensland, Australia
)
Hanlee JiStanford University, USA
)
Heather Ritchie-ParkerRoyal Zoological Society of Scotland, UK
I
)
Prof. Ian AbbsGuy’s and St Thomas’ NHS Foundation Trust, UK
)
Dr. Inès HassanTony Blair Institute for Global Change, UK
J
)
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
)
Prof. Sir John BellEllison Institute of Technology Oxford, UK
)
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
)
Julie DragonUniversity of Vermont, USA
)
Dr. Janessa LaskinBC Cancer Centre & University of British Columbia, Canada
)
Joanne TrinhInstitute of Neurogenetics, Germany
)
Prof. Joris VermeeschKU Leuven, Belguim
)
Jose-Crispin Zavala AlvaradoPathoQuest, France
K
)
Kimberley BillingsleyNational Institutes of Health, USA
)
Kara DicksProgramme Manager, Conservation Genomics—ORG.ONE, Oxford Nanopore Technologies
)
Dr. Karen SherwoodUniversity of British Columbia, Canada
)
Katharina WolffTU Braunschweig, Germany
L
)
Lyn ChittyGreat Ormond Street NHS Foundation Trust & UCL Great Ormond Street Institute of Child Health, UK
)
Lauren LuiLawrence Berkeley National Laboratory, USA
)
Dr. Luke W. MeredithWHO-EMRO World Health Emergencies, Egypt
)
Dr. Luca MazzarellaEuropean Institute of Oncology, Italy
)
Prof. Laurent MesnardSorbonne University, France
)
Lorey SmithPeter MacCallum Cancer Centre, Australia
)
Lara UrbanHemholtz AI, Germany
M
)
Medini AnnavajhalaColumbia University Irving Medical Center, USA
)
Mark AkesonUniversity of California, Santa Cruz, USA
)
Prof. Matt BrownGenomics England, UK
)
Morgan GueuningBlood Transfusion Service, Switzerland
)
Morghan LucasMedical Genetics Center, Germany
Michael NakaiPeter MacCallum Cancer Centre, Australia
)
Dr. Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
)
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
)
Mrinalini WatsaSan Diego Zoo Wildlife Alliance, USA
N
)
Natalia GarciaBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Ndack NdiayePasteur Institute, Senegal
)
Nick SeddonOptum Genomics, USA
P
)
Paul ArvidsonGenomics England & SWAN, UK
)
Ping LuPeking University, China
)
Prof. Dr. Pieter WesselingPrincess Máxima Center for Pediatric Oncology & Amsterdam University Medical Centers, The Netherlands
R
)
Dr. Rahul BatraGuy's & St Thomas' Hospital NHS Trust, UK
)
Rui ChenBaylor College of Medicine, USA
)
Rea KobialkaInstitute of Animal Hygiene and Veterinary Public Health, Germany
)
Rachel RubinsteinManager, Software Technical Product Management, Oxford Nanopore Technologies
)
Rosemary Sinclair DokosSVP, Product and Programme Management, Oxford Nanopore Technologies
)
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
S
)
Sergey BatalovRady Children’s Institute for Genomic Medicine, USA
)
Seanne P. BuckwalterMayo Clinic, USA
)
Sam DavisPrincipal Scientist, Machine Learning, Oxford Nanopore Technologies
)
Sneha GoenkaStanford University & Princeton University, USA
)
Sarah GriffithsBioinformatics Workflow Developer, Oxford Nanopore Technologies
)
Sirisha HeskethClinical Bioinformatician, Oxford Nanopore Technologies
Sofia KudashevaEarlham Institute, UK
)
Susie LeeTechnical Product Manager, Basecalling and Models, Oxford Nanopore Technologies
)
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
)
Dr. Simon PaineNottingham University Hospitals NHS Trust, UK
)
Steph WilbrahamDirector, Automation Product Management, Oxford Nanopore Technologies
)
Spike WillcocksChief Strategy Officer, Oxford Nanopore Technologies
T
)
Thias Oberg BoesenNovo Nordisk A/S, Denmark
)
Tomás Di DomenicoNational Cancer Research Center, Spain
)
Tomasz DobrzyckiField Applications Scientist, New Product Introduction, Oxford Nanopore Technologies
)
Dr. Telmo GraçaLonza, Switzerland
)
Tina HanTwist Bioscience
)
Dr. Thomas R. KreilTakeda, Austria
)
Tetyana VasylyevaUniversity of California, Irvine, USA
)
)
)
Oxford Nanopore Technologies
Dr. Carolyn Tregidgo
)
- Job title
- Institution
- VP, Late Stage and Applied Product Development, Oxford Nanopore Technologies
- Biography
Dr. Carolyn Tregidgo is a technical leader with significant experience in DNA sequencing of rare disease and cancer genomes, as well as product development of DNA sequencing technology. With a background in biophysics, Carolyn completed her PhD in fluorescence microscopy before joining Illumina where she worked on the development of multiple sequencing platforms. Carolyn went on to join Genomics England where she led the bioinformatics delivery team responsible for integration of new pipeline developments and return of results to the participants of the 100,000 Genome Project. During her time at Genomics England, she also managed the pipeline deployment to monitor severe response to COVID-19 and oversaw the successful regulated workflow development of the Genomic Medicine Service. In 2020, Carolyn joined Exact Sciences Innovation, formally Base Genomics — a spinout company from Oxford University, where she was head of R&D. Since August 2023, Carolyn has been Vice President of Late Stage and Applied development at Oxford Nanopore Technologies where she is responsible for the development of the regulated product lines.